SLC5A2 and hydrops fetalis: The objective of this study was to stratify hospitalized patients with HF with and without declining ADL to examine whether there is a difference in the degree of the impact of SGLT2 inhibitor administration on readmission (all hospitalizations or HF readmissions) within one year.